文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.

作者信息

Zhang Hongmei, Li Yan, de Carvalho-Barbosa Marianna, Kavelaars Annemieke, Heijnen Cobi J, Albrecht Phillip J, Dougherty Patrick M

机构信息

Department of Anesthesia and Pain Medicine Research, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.

Department of Symptom Research, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.

出版信息

J Pain. 2016 Jul;17(7):775-86. doi: 10.1016/j.jpain.2016.02.011. Epub 2016 Mar 12.


DOI:10.1016/j.jpain.2016.02.011
PMID:26979998
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4939513/
Abstract

UNLABELLED: Chemotherapy-induced peripheral neuropathy (CIPN) is a disruptive and persistent side effect of cancer treatment with paclitaxel. Recent reports showed that paclitaxel treatment results in the activation of Toll-like receptor 4 (TLR4) signaling and increased expression of monocyte chemoattractant protein 1 (MCP-1) in dorsal root ganglion cells. In this study, we sought to determine whether an important consequence of this signaling and also a key step in the CIPN phenotype was the recruitment and infiltration of macrophages into dorsal root ganglia (DRG). Here, we show that macrophage infiltration does occur in a time course that matches the onset of the behavioral CIPN phenotype in Sprague-Dawley rats. Moreover, depletion of macrophages by systemic administration of liposome-encapsulated clodronate (clophosome) partially reversed behavioral signs of paclitaxel-induced CIPN as well as reduced tumor necrosius factor α expression in DRG. Intrathecal injection of MCP-1 neutralizing antibodies reduced paclitaxel-induced macrophage recruitment into the DRG and also blocked the behavioral signs of CIPN. Intrathecal treatment with the TLR4 antagonist lipopolysaccharide-RS (LPS-RS) blocked mechanical hypersensitivity, reduced MCP-1 expression, and blocked the infiltration of macrophages into the DRG in paclitaxel-treated rats. The inhibition of macrophage infiltration into DRG after paclitaxel treatment with clodronate or LPS-RS prevented the loss of intraepidermal nerve fibers (IENFs) observed after paclitaxel treatment alone. These results are the first to indicate a mechanistic link such that activation of TLR4 by paclitaxel leads to increased expression of MCP-1 by DRG neurons resulting in macrophage infiltration to the DRG that express inflammatory cytokines and the combination of these events results in IENF loss and the development of behavioral signs of CIPN. PERSPECTIVE: This paper shows that activation of innate immunity by paclitaxel results in a sequence of signaling events that results in the infiltration of the dorsal root ganglia by activated macrophages. Macrophages appear to drive the development of behavioral hypersensitivity and the loss of distal epidermal nerve fibers, and hence play an important role in the mechanism of paclitaxel-related neuropathy.

摘要

相似文献

[1]
Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.

J Pain. 2016-7

[2]
Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.

J Pain. 2014-7

[3]
MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy.

Brain Behav Immun. 2015-10

[4]
Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy.

J Pain. 2013-5-31

[5]
CX3CL1-mediated macrophage activation contributed to paclitaxel-induced DRG neuronal apoptosis and painful peripheral neuropathy.

Brain Behav Immun. 2014-3-26

[6]
Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells.

Exp Neurol. 2007-1

[7]
Dorsal root ganglion neurons become hyperexcitable and increase expression of voltage-gated T-type calcium channels (Cav3.2) in paclitaxel-induced peripheral neuropathy.

Pain. 2017-3

[8]
The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4.

J Neurosci. 2015-9-30

[9]
DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.

J Neurosci. 2017-12-18

[10]
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats.

Brain Behav Immun. 2007-7

引用本文的文献

[1]
Therapeutic Potential of BMX-001 for Preventing Chemotherapy-Induced Peripheral Neuropathic Pain.

Pharmaceuticals (Basel). 2025-8-5

[2]
Paclitaxel-induced adverse effects: insights into multi-organ toxicities and molecular mechanisms.

Naunyn Schmiedebergs Arch Pharmacol. 2025-8-27

[3]
Mechanisms and Management of Albumin-Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer.

Breast Cancer (Dove Med Press). 2025-8-13

[4]
Molecular Mechanisms of Chronic Pain and Therapeutic Interventions.

MedComm (2020). 2025-8-7

[5]
Anti-Inflammatory Pathways Mediating tDCS's Effects on Neuropathic Pain.

Biology (Basel). 2025-7-20

[6]
The CXCL1-CXCR2 Axis as a Component of Therapy Resistance, a Source of Side Effects in Cancer Treatment, and a Therapeutic Target.

Cancers (Basel). 2025-5-15

[7]
Diverse cell types establish a pathogenic immune environment in peripheral neuropathy.

J Neuroinflammation. 2025-5-23

[8]
Neuroprotectin D1 and GPR37 protect against chemotherapy-induced peripheral neuropathy and the transition from acute to chronic pain.

Pharmacol Res. 2025-6

[9]
Potassium/Sodium Citrate Attenuates Paclitaxel-Induced Peripheral Neuropathy.

Int J Mol Sci. 2025-4-3

[10]
Inflammation and macrophage infiltration exacerbate adult incision response by early life injury.

BMC Anesthesiol. 2025-4-10

本文引用的文献

[1]
The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4.

J Neurosci. 2015-9-30

[2]
MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy.

Brain Behav Immun. 2015-10

[3]
Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.

Cancer Res. 2014-10-1

[4]
A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy.

Cancer Res. 2014-11-1

[5]
Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation density.

J Clin Oncol. 2014-10-1

[6]
Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.

J Pain. 2014-7

[7]
CX3CL1-mediated macrophage activation contributed to paclitaxel-induced DRG neuronal apoptosis and painful peripheral neuropathy.

Brain Behav Immun. 2014-3-26

[8]
Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy.

J Pain. 2013-5-31

[9]
Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine.

Cancer Chemother Pharmacol. 2012-12-11

[10]
Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.

Neuro Oncol. 2012-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索